Press Release August 12, 2021Is Regeneron Pharmaceuticals (REGN) Stock Outpacing Its Medical Peers This Year? 0 0 Share
Company Ticker News August 5, 2021Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer 0 0 Share
Company Ticker News August 5, 2021Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook 0 0 Share
Company Ticker News August 5, 2021Regeneron Earnings Top Estimates. Its Stock May Be Breaking Out. 0 0 Share
Company Ticker News August 5, 2021Regeneron shares jump 3.3% premarket after earnings blow past estimates; COVID antibody sales total $2.59 billion 0 0 Share
Company Ticker News August 5, 2021Regeneron quarterly profit surges on COVID-19 antibody cocktail demand 0 0 Share
Press Release August 5, 2021Phase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with Chemotherapy Stopped Early Due to Significant Improvement in Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer 0 0 Share
Press Release August 5, 2021Phase 3 trial of Libtayo® (cemiplimab) combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer 0 0 Share
Company Ticker News August 5, 2021Regeneron Reports Second Quarter 2021 Financial and Operating Results 0 0 Share
